Norris Medicines Ltd. Press Release Feb 10 2025

NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve 1. To consider and approve Un-audited Financial Results for the quarter ended 31st December, 2025 along with Limited Review Report and Statement of Asset and Liability thereof.2. To consider and approve requests regarding from Mr. Nimish Bhishma Thakore, Promoter / Promoter Group for reclassification from 'Promoter / Promoter Group' into Public Category to 'Public' Category in accordance with the Regulation 31A of SEBI (LODR) Regulation 2015.3. Any other business with the permission of Chair.

View Attachment